Clearmind Medicine (CMND) Income Statement: Revenue & Earnings

Clearmind Medicine Income Statement Analysis

Revenue, earnings, and profit margins in millions CAD

Scale:

Scroll to see more

Clearmind Medicine Inc. income statement - Annual data in millions CAD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021	Oct 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	2.06	1.38	1.54	3.08	0.47	0.00
Selling, General & Administrative	3.57	4.32	4.76	3.10	2.22	0.18
Operating Expenses	5.67	5.74	6.30	6.25	2.69	0.31
Operating Income	-5.67	-5.74	-6.30	-6.25	-2.69	-0.31
Other Income/Expense
Interest Income	0.13	0.27	0.09	0.00	0.00	0.00
Interest Expense	0.02	0.04	-0.01	0.01	0.00	0.00
Other Income/Expense	1.77	0.63	-2.19	-0.60	-0.03	0.00
Income
Income Before Tax	-3.79	-4.88	-8.60	-6.87	-2.73	-0.31
Income Tax Expense	0.07	0.38	0.02	0.03	0.00	0.00
Net Income	-3.86	-5.25	-8.62	-6.89	-2.73	-0.31
Net Income - Continuous Operations	-3.86	-5.25	-8.62	-6.89	-2.73	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-3.72	-4.79	-6.28	-6.77	-2.69	-0.18
EBIT	-3.77	-4.84	-6.30	-6.85	-2.69	-0.31
Depreciation & Amortization	0.04	0.04	0.02	0.07	0.00	0.14
Earnings Per Share
Basic EPS	-30.00	-68.00	-1703.00	-6384.00	-2615.00	-
Diluted EPS	-30.00	-68.00	-1703.00	-6384.00	-2615.00	-
Basic Shares Outstanding	0.13	0.08	0.01	0.00	0.00	0.00
Diluted Shares Outstanding	0.13	0.08	0.01	0.00	0.00	0.00